
SPAIN - Talde-backed Biópolis expands its capital
Talde Gestión backed biotechnology company Biópolis will undertake a capital expansion to acquire new facilities and increase production.
The Valencia-based company specialises in the development of micro-organisms for use in the agrofood sector. The capital injection will also allow the company to expand its operation into the pharmaceutical sector. It projects a turnover of EUR 2m and a 25-30% increase in growth.
The capital expansion should not alter the position of the various investors in the company which include research entity CSIC with 35%, technology player Natraceutical with 25%, Asturian milk producer Capsa with 20% and la Talde with 15%.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater